Sign In
Buy LGVN
$0.80
-0.0197 (-2.40%)
At Close: Jun 22, 2026
LGVN Stock Alert: Longeveron Pops 18% on FDA Fast-Track Designation
10:19am, Wednesday, 17'th Jul 2024
Longeveron (NASDAQ: LGVN ) stock is rocketing higher on Wednesday after the clinical-stage biotechnology company received fast-track designation for its mild Alzheimer's Disease treatment. This has th
7 Meme Stocks That Deserve a Fresh Set of Eyes
06:00am, Wednesday, 17'th Jul 2024
Meme stocks – you know them as social-media-inspired securities that tend to be speculative. Generally speaking, it's difficult to suggest otherwise.
Longeveron stock opened 100% up on Wednesday: explore why
11:38am, Wednesday, 10'th Jul 2024
Longeveron Inc (NASDAQ: LGVN) soared 100% on Wednesday after its Lomecel-B received RMAT designation from the Food & Drug Administration. Lomecel-B is the company's investigational treatment for Alz
Why Is Longeveron (LGVN) Stock Up 53% Today?
11:34am, Wednesday, 10'th Jul 2024
Longeveron (NASDAQ: LGVN ) stock is rocketing higher on Wednesday after the clinical-stage biotechnology company announced a new designation from the Food and Drug Administration (FDA). This has the F
Longeveron® Announces U.S. FDA Grants Lomecel-B(TM) Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer's Disease
Neha Motwani Elected to Longeveron® Board of Directors
09:00am, Tuesday, 09'th Jul 2024
MIAMI, July 09, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic agi
Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors
09:00am, Monday, 08'th Jul 2024
Gene therapy pioneer Dr. Roger Hajjar elected to Longeveron Board of Directors as company advances it novel cellular therapy across multiple indications.
3 Penny Stocks Poised to Turn Pocket Change Into a Small Fortune by 2028
10:30am, Wednesday, 19'th Jun 2024
Penny stocks are a tripwire for mayhem. They can easily blow up your portfolio.
Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise Transaction
04:48pm, Tuesday, 18'th Jun 2024
MIAMI, June 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular thera
Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024
09:00am, Monday, 17'th Jun 2024
Longeveron, a clinical stage biotechnology company developing cellular therapies, will present at the Virtual LIfe Sciences Investor Forum on June 20th.
Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds
08:38am, Monday, 17'th Jun 2024
MIAMI, June 17, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular thera
Why has Longeveron stock tripled in two days?
09:45am, Thursday, 13'th Jun 2024
Longeveron Inc (NASDAQ: LGVN) rallied another 50% on Thursday as investors continued to celebrate the positive update of its Lomecel-B study. Why is it significant for Longeveron stock?
Why Is Longeveron (LGVN) Stock Up 46% Today?
08:15am, Thursday, 13'th Jun 2024
Longeveron (NASDAQ: LGVN ) stock continues to rally on Thursday as investors celebrate positive trial news from the clinical-stage biotechnology company. The big news that boosted shares of LGVN stoc
Why Is Longeveron (LGVN) Stock Up 120% Today?
04:45pm, Wednesday, 12'th Jun 2024
The clinical-stage biotech market is as vast as it is complicated. Companies operating in this space are wide-ranging in the illnesses they look to treat.
Longeveron® Announces Contract Development and Manufacturing Business and First Contract
09:00am, Monday, 03'rd Jun 2024
Longeveron launches contract development and manufacturing business for stem cell therapies. 15,000 sf state-of-the-art GMP facility with 8 cleanrooms.
